Communication as Mediator: Interprofessional Deprescribing and the RCC (Roles–Collaboration–Communication) Framework
Polypharmacy remains a significant challenge, often leading to adverse drug events and increased healthcare costs.
Polypharmacy remains a significant challenge, often leading to adverse drug events and increased healthcare costs.
Sickle cell disease (SCD) is a systemic disorder marked by chronic pain and neurocognitive deficits, yet the molecular drivers of these neurocognitive features remain poorly defined.
The data used in this secondary analysis were originally collected under NIH grants K23 RR020788 (IRB# 7917) and R15 NR008862 (IRB# 8365) and by the University of Tennessee Health Science Center (GCRC M01 RR00211).